The healthcare company plans to release future financial plans while its shares went up by 0.05% during the last trading session.
The Health care services company, Cardinal Health Inc. has announced that it will release its first-quarter financial results of fiscal year 2016 on November 2, 2015. They have planned to release the financial results of the first quarter before the New York Stock Exchange market initiates trading on that day. The health services company has arranged a webcast along with a conference call on November 2, 8:30 a.m. (Eastern).
As of September 30, 2015, the healthcare company's shares were being traded at a share price of $76.77, which was a 0.05% increase in the share price that took place during the trading session that was held previously. During the course of the last trading session, the shares were traded at $76.72 and closed down with the shares volume at 2,796,227 shares.
The session began with $76.95 and during the course, the share price fluctuated between $76.25 and $78.36. With the former being the lowest the share price was observed at and the latter being the highest point that the share price touched.
Current market capital of Cardinal Health is $25.33 billion and the earnings per share reported by the company on October 2, 2015 are 3.62 along with the price to earnings ratio of 21.36. The number of outstanding shares of the healthcare provider is 328,840,000.
In a year's time, the medical services company saw the share price go as high as $91.91 and as low as $71.724. The 52-week high was witnessed on April 27, 2015 and a 52-week low was seen on October 15, 2014. In a year, the company's stock has increased by 2.94%
15 brokerage firms have rated Cardinal Health; the rating that the medial care services company has received from these firms is 1.53. Stock analysts and researchers at Zacks, a research firm, have given the company a rating of "Buy" in the short term with a ranking of 2.
The stock of Cardinal Health has managed to get into the Hold List of almost 3 stock experts and 2 have recommended that the health care service provider is a "Buy". At the end, 10 have said that the company is a strong buy.
Insider Trading activities have also been detected in the company according to the information that was unveiled by the company to the SEC on a form 4 filing. According to this unveiled data, the Chairman and CEO of the healthcare firm sold 300,000 shares. This transaction conducted on August 20, 2015 was worth $24,924,000 as each share was sold at a price of $83.08. Insiders investors currently on 0.3% of the company while institutional investors own 87.8%.